[30-503-am] Drug delivery system in oncotherapy/Targeting/Controlled release/Others

Sat. Mar 30, 2024 10:45 AM - 11:45 AM [Room 503] Conference Center 503 (5F)

Chair: Shigeru Kawakami, Ryo Suzuki

+Add all to schedule

10:45 AM - 10:57 AM

[30-503-am01S] A study on induction of anti-tumor effect by combination of cancer peptide vaccine targeting splenic marginal zone B cells and a chemotherapeutic agent

○Yuri Deai¹, Taro Shimizu², Hidenori Ando^1,3, Tatsuhiro Ishida^1,3 (1. Grad. Sch. of Pham., Tokushima Univ., 2. Inst. Microbial Dis., Osaka Univ., 3. DDS Res. Cent., Tokushima Univ.)

10:57 AM - 11:09 AM

[30-503-am02S] Glutathione Prodrug that is Effectively Activated in CD44 Variant Isoform High-Expressing Cancer Cells

○Tomona Yukimura¹, Manae Ogawa¹, Mayu Ito¹, Kohei Motohashi¹, Tomohiro Seki¹, Toshinobu Seki¹ (1. Josai Univ. Pharm.)

11:09 AM - 11:21 AM

[30-503-am03S] Efficient loading of siRNA to extracellular vesicles using extracellular vesicle-targeting motifs

○Haruya Hirano¹, Kosuke Kusamori¹, Shoko Itakura¹, Yuri Katsurada², Kenji Hyodo², Makiya Nishikawa¹ (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Sci., 2. Eisai Co., Ltd.)

11:21 AM - 11:33 AM

[30-503-am04S] Improvement of mRNA stability and biocompatibility by using self-gelatinizable nucleic acids

○Takumi Tanifuji¹, Kosuke Kusamori¹, Shoko Itakura¹, Makiya Nishikawa¹ (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Sci.)

11:33 AM - 11:45 AM

[30-503-am05S] Effect of serum protein binding on cellular uptake of antisense and DNA/RNA heteroduplex oligonucleotides

○Natsuki Makiguchi¹, Yukitake Yoshioka¹, Kosuke Kusamori¹, Shoko Itakura¹, Syunsuke Yamamoto², Shinji Iwasaki², Hideki Hirabayashi², Hiroyuki Kusuhara³, Tetsuya Nagata⁴, Takanori Yokota⁴, Makiya Nishikawa¹ (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Science, 2. Takeda Pharmaceutical Co., Ltd., 3. Univ. Tokyo, 4. Tokyo Med. Dent. Univ.)

Session information